Baird lowered the firm’s price target on Definitive Healthcare (DH) to $1.90 from $3 and keeps a Neutral rating on the shares. The firm updated its model following Q4 results.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DH:
- Definitive Healthcare price target lowered to $2 from $3 at Stephens
- Hold Rating Maintained Amid Weaker FY26 Outlook, Margin Pressure, and Uncertain Recovery Timing
- Definitive Healthcare price target lowered to $3 from $4 at Canaccord
- Definitive Healthcare reports Q4 adjusted EPS 6c, consensus 6c
- Definitive Healthcare sees Q1 adjusted EPS 3c, consensus 6c